Drug Shortage Report for RESTASIS MULTIDOSE

Last updated on 2025-04-05

Report ID 239176
Drug Identification Number 02476835
Brand name RESTASIS MULTIDOSE
Common or Proper name Restasis Multidose
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) CYCLOSPORINE
Strength(s) 0.05%
Dosage form(s) EMULSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 7mL
ATC code S01XA
ATC description OTHER OPHTHALMOLOGICALS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-10-11
Actual start date
Estimated end date 2025-04-11
Actual end date 2025-04-04
Shortage status Resolved
Updated date 2025-04-05
Company comments Manufacturing delay
Health Canada comments
Tier 3 Status No
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-04-05 English Compare
v9 2025-04-04 French Compare
v8 2025-04-04 English Compare
v7 2025-02-12 French Compare
v6 2025-02-12 English Compare
v5 2024-10-29 French Compare
v4 2024-10-29 English Compare
v3 2024-10-12 English Compare
v2 2024-10-03 French Compare
v1 2024-10-03 English Compare

Showing 1 to 10 of 10